Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 31;5(3):e1087637.
doi: 10.1080/2162402X.2015.1087637. eCollection 2016 Mar.

Targeted immunotherapy for pediatric solid tumors

Lisa M Kopp  1 , Emmanuel Katsanis  1
Affiliations
Review

Targeted immunotherapy for pediatric solid tumors

Lisa M Kopp et al. Oncoimmunology. .

Abstract

Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

Keywords: Immunotherapy; pediatric oncology; solid tumors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics. CA Cancer J Clin 2014; 64(2):83-103; PMID:24488779; http://dx.doi.org/10.3322/caac.21219 - DOI - PubMed
    1. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nature Reviews Cancer 2014; 14(1):61-70; PMID:24304873; http://dx.doi.org/10.1038/nrc3634 - DOI - PMC - PubMed
    1. Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R. Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer 2014; 120(4):548-54; PMID:24166473; http://dx.doi.org/10.1002/cncr.28461 - DOI - PMC - PubMed
    1. Navid F, Santana VM, Barfield RC. Anti-GD2 antibody therapy for GD2-expressing tumors. Curr Cancer Drug Targets 2010; 10(2):200-9; PMID:20201786; http://dx.doi.org/10.2174/156800910791054167 - DOI - PMC - PubMed
    1. Capitini CM, Mackall CL, Wayne AS. Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther 2010; 10(2):163-78; PMID:19947897; http://dx.doi.org/10.1517/14712590903431022 - DOI - PMC - PubMed

LinkOut - more resources